REG - Oxford Biomedica PLC - Holdings in Company

Oxford BioMedicaAnnouncement

28/01/2022 14:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220128:nRSb0266Aa&default-theme=true

RNS Number : 0266A  Oxford Biomedica PLC  28 January 2022

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDFBVT43

Issuer Name

OXFORD BIOMEDICA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An event changing the breakdown of voting

3. Details of person subject to the notification obligation

Name

Novo Holdings A/S

City of registered office (if applicable)

Hellerup

Country of registered office (if applicable)

 

 Name                     City of registered office  Country of registered office
 Novo Nordisk Foundation  Hellerup                   Denmark

 

4. Details of the shareholder

 Name               City of registered office  Country of registered office
 Novo Holdings A/S  Hellerup                   Denmark

 

5. Date on which the threshold was crossed or reached

01-Jun-2021

6. Date on which Issuer notified

27-Jan-2022

7. Total positions of person(s) subject to the notification obligation

                                                    % of voting rights attached to shares (total  % of voting rights through financial instruments (total  Total of both in % (8.A + 8.B)  Total number of voting rights held in

                                                    of 8.A)                                       of 8.B 1 + 8.B 2)                                                                        issuer
 Resulting situation on the date on which

 threshold was                                      9.570000                                      0.000000                                                 9.570000                        8253000
 crossed or reached
 Position of previous notification (if applicable)

 

 

8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached

8A. Voting rights attached to shares

 Class/Type of shares ISIN code(if possible)  Number of direct voting rights (DTR5.1)  Number of indirect voting                                       % of indirect voting rights (DTR5.2.1)

                                                                                       rights (DTR5.2.1)          % of direct voting rights (DTR5.1)
 GB00BDFBVT43                                 8253000                                  0                          9.570000                             0.000000
                                              8253000                                                             9.570000%

 Sub Total 8.A

 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

                                                                               Number of voting rights that may be acquired if the instrument is  % of voting rights

                            exercised/converted
 Type of financial instrument   Expiration date   Exercise/conversion period
 Sub Total 8.B1

 

8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))

 Type of financial instrument  Expiration date  Exercise/conversion period  Physical or cash settlement  Number of voting rights  % of voting rights
 Sub Total 8.B2

 

9. Information in relation to the person subject to the notification
obligation

1. Person subject to the notification obligation is not controlled by any
natural person or legal entity and does not control any other undertaking(s)
holding directly or indirectly an interest in the (underlying) issuer.

 Ultimate controlling person  Name of controlled undertaking  % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial instruments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold
                                                                                                                                          than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

The position of Novo Holdings A/S in its previous TR-1 notification was 10.1%.
This notification obligation has arisen as a result of issuances of shares by
the issuer (and not a disposal of shares by Novo Holdings A/S) and is based
upon the latest total voting rights announcement of the issuer dated 4 January
2022.

The qualifying instruments are held by Novo Holdings A/S, the holding company
in the Novo Group. Novo Holdings A/S is wholly owned by the Novo Nordisk
Foundation.

12. Date of Completion

27-Jan-2022

13. Place Of Completion

London, United Kingdom

 Contact name:              Natalie Walter
 Contact telephone number:  01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLEADFPALPAEFA